Evidence map›Paper›PMID 16437197›Full record

ArticleIntensive care medicine2006

Elevation in interleukin 13 levels in patients diagnosed with systemic inflammatory response syndrome.

Luis A Socha, John Gowardman, Diego Silva, Manuel Correcha, Nikolai Petrosky

Abstract read
PubMed Publisher
In one paragraph

Article in Intensive care medicine, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Soluble interleukin-13rα1: a circulating regulator of glucose.American journal of physiology. Endocrinology and metabolism · 2017
    Trial
  2. Review
  3. Traumatic inflammatory response: pathophysiological role and clinical value of cytokines.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Cytokines in the systemic inflammatory response syndrome: a review.HSR proceedings in intensive care & cardiovascular anesthesia · 2010
    Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Luis A SochaJohn Curtin School of Medical Research, Australian National University, ACT 2601, Canberra, Australia.
John GowardmanIntensive Care Unit, Launceston General Hospital, TAS 7250, Launceston, Australia. john.gowardman@dhhs.tas.gov.au.
Diego SilvaJohn Curtin School of Medical Research, Australian National University, ACT 2601, Canberra, Australia.
Manuel CorrechaJohn Curtin School of Medical Research, Australian National University, ACT 2601, Canberra, Australia.
Nikolai PetroskyDepartment of Endocrinology, Flinders Medical Centre, SA 5042, Adelaide, Australia.
Australian National University · AUCanberra Hospital · AUFlinders Medical Centre · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo examine plasma levels and circadian rhythm of interleukin 13 (IL-13), tumour necrosis factor (TNF) alpha and total serum cortisol in the systemic inflammatory response syndrome (SIRS). DESIGN AND

settingProspective observational study in a 12-bed medical-surgical ICU of a 500-bed university hospital. PATIENTS: Ten patients with SIRS and eight controls. MEASUREMENTS: Arterial blood was sampled hourly for 24 h for measurement of plasma IL-13, TNF- alpha, cortisol and white blood cell count (WCC) differential within 24 h of development of SIRS.

resultsThere were significantly higher plasma IL-13 levels in SIRS patients than in controls (1282 vs. 713 pg/ml). IL-13 was significantly higher in patients with a diagnosis of sepsis than in those with non-infectious causes of SIRS (2080 vs. 515 pg/ml). In SIRS the elevation in IL-13 was associated with higher TNF-alpha and reduced WCC. A circadian rhythm was observed in plasma IL-13 secretion. No distinct circadian rhythm was noted for TNF- alpha, and the normal circadian rhythm of serum cortisol was lost.

conclusionsThe anti-inflammatory cytokine IL-13 is elevated in early SIRS. Its plasma level exhibits a circadian rhythm and may be modulated in part by TNF-alpha. SIRS patients have disruption of the normal circadian rhythm of serum cortisol.

Indexed as

AgedAnalysis of VarianceCase-Control StudiesCircadian RhythmFemaleHumansHydrocortisoneInterleukin-13Leukocyte CountMaleMiddle AgedProportional Hazards ModelsProspective StudiesStatistics, NonparametricSystemic Inflammatory Response SyndromeTumor Necrosis Factor-alphaHydrocortisoneInterleukin-13Tumor Necrosis Factor-alpha

Identifiers

PMID16437197
OpenAlexW2036091331

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.